Fritextsökning
Artiklar per år
Innehållstyper
-
Dermafol får ny bolagsledare
Läkemedelsföretaget Dermafol rekryterar IP-konsult till vd-posten.
-
Nytta/risk äntligen etablerat
I dessa avseenden är EMA minst jämbördig med FDA
-
Strömlinjeformar läkemedelsutveckling
It-jätten Oracle släpper en ny version av sin mjukvara Agile Product Lifecycle Management, PLM.
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming, e-solutions company for clinical trials, eager to thrive on this development.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Flera chefsstolar står tomma
På flera life science-bolag finns tomma chefspositioner, men det råder ingen chefsbrist i Sverige menar rekryteraren Peter Åberg.
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and sourcing of resources.
-
This is Sweden's largest life science region
About 60 percent of all jobs within swedish life science are found in the Stockholm-Uppsala area. This was stated in a report presented at Scanlab & Biotech Forum today.
-
Nya bestämmelser på gång
Bristen på insyn vid handel via kapitalförsäkringar har blivit ett växande problem och branschen välkomnar nu en regeländring.
-
Exhibitors
Register of exhibitors and where they can be found.
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
High hopes for future partnering - the solution for struggling fairs
Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.
-
Hallå där Peter Bramberg...
... som ansvarar för life science på Invest Sweden, vad är viktigast att den kommande regeringen genomför för life science-sektorn?
-
Ny regionchef på BMS
Bristol-Myers Squibb slår ihop flera regioner under nya vd:n Antonio Pratto.
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continue to invest in further development.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performers have companies in phase III, according to Biotech Scandinavia's survey.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Countries with a clear research goal are investing in new parks, and in China, the number is growing exponentially.
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
150 miljoner från ny ägare i Active Biotech
Lundabolaget Active Biotech tar in pengarna från de nya ägarna i en nyemission.
-
Bioinvent tar in 150 miljoner
Läkemedelsbolaget fyller på i kassan i en riktad nyemission.
-
Samarbetsdags för Big Pharma
Patientkontakt via sociala medier, mobilstödd övervakning av dosering eller datastödd läkemedelsutveckling. Framtidens big pharma-bolag måste vidga vyerna och leverera hälsoresultat i stället för läkemedel, enligt Ernst&Youngs senaste rapport Progressions, Pharma 3.0.
-
Gisela Sitbon tar plats i Beacticas styrelse
Drug discovery företaget Beactica har utsett Gisela Sitbon på Innovationsbron till ny styrelseledamot.
-
Fem bolag får stöd från Göteborgbio
Av 48 sökanden uppfyllde fem bolag kriterierna och delar på två miljoner kronor, men inte alla fick det maximala stödet på 500 000 kronor.